Compare CARsgen Therapeutics Holdings Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of 209.39% and Operating profit at 3.37% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -73.62
2
Risky -
3
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.1%
0%
12.1%
6 Months
3.49%
0%
3.49%
1 Year
-22.86%
0%
-22.86%
2 Years
172.32%
0%
172.32%
3 Years
54.96%
0%
54.96%
4 Years
55.78%
0%
55.78%
5 Years
0%
0%
0.0%
CARsgen Therapeutics Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
209.39%
EBIT Growth (5y)
3.37%
EBIT to Interest (avg)
-73.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.30
Sales to Capital Employed (avg)
0.05
Tax Ratio
0.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.98
EV to EBIT
-17.80
EV to EBITDA
-20.23
EV to Capital Employed
-27.62
EV to Sales
89.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-34.19%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
136.30
42.70
219.20%
Operating Profit (PBDIT) excl Other Income
-223.10
-577.10
61.34%
Interest
7.50
6.20
20.97%
Exceptional Items
0.00
-205.00
100.00%
Consolidate Net Profit
-111.60
-865.40
87.10%
Operating Profit Margin (Excl OI)
-1,872.00%
-15,519.00%
1,364.70%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 219.20% vs 0.00% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 87.10% vs -4.73% in Dec 2024
About CARsgen Therapeutics Holdings Ltd. 
CARsgen Therapeutics Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






